Healthcare
Novavax Stock Jumps Due to COVID-19 Vaccine Trial Results
Is Sorrento Therapeutics a Good Bet for Investors?
Sorrento Therapeutics stock has surged 280 percent year-to-date. Will the rally continue?
Which Hand Sanitizers Have Been Recalled?
Prescription Marketplace GoodRx Reportedly Files for IPO
The report of a GoodRx IPO filing comes after the Silver Lake–backed startup's move to strengthen its executive team.
RLF-100 or Aviptadil Could Offer Rapid Treatment for Coronavirus
Moderna Stock Soars, COVID-19 Vaccine Looks Promising
Moderna (NASDAQ:MRNA) stock surged 16% in after-market trading hours on Tuesday following news of positive results related to its COVID-19 vaccine.
Moderna Will Join Nasdaq 100, Jefferies Assigns ‘Buy’ Rating
Moderna will become a component of the NASDAQ 100 Index beginning on July 20. The stock will replace the CoStar Group in the NASDAQ-100.
Novavax Rose 33% Due to $1.6 Billion COVID-19 Funding
Today at 9:08 AM ET, Novavax stock rose 32.7% to $105.19 in the pre-market session. The company received $1.6 billion for its COVID-19 vaccine candidate.
Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?
Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.
Pfizer Soars Due to Hopes about a Coronavirus Vaccine
Pfizer (NYSE:PFE) stock rose 2.4% in pre-market trading at 7:51 AM ET today. The company’s experimental COVID-19 vaccine showed positive results.
If You Own Intercept Stock, Should You Sell It Now?
On Monday, Intercept Pharmaceuticals (NASDAQ:ICPT) stock lost 39.7% and closed at $46.70 with a market cap of $1.54 billion.
Brazil Agrees to Produce AstraZeneca’s COVID-19 Vaccine
AstraZeneca (NYSE:AZN) stock rose 1.4% in pre-market trading at 5:56 AM ET today. Brazil will manufacture AstraZeneca’s experimental coronavirus vaccine.
Moderna Partners with Catalent on Potential COVID-19 Vaccine
Today, biotechnology company Moderna announced its collaboration with Catalent for large-scale manufacturing of its potential COVID-19 vaccine.
Moderna Announces Phase 3 Trial in July for COVID-19 Vaccine
Moderna stock has risen 5.1% as of 10:38 AM ET today. The phase 3 study for the mRNA-1273 vaccine candidate against COVID-19 will start in July.
Gilead Stock Rose Due to AstraZeneca Takeover Offer
Gilead Sciences stock rose 4.4% in pre-market trading at 7:32 AM ET today. AstraZeneca approached Gilead Sciences about a potential merger.
Will Novavax Win the COVID-19 Vaccine Race?
Today at 7:52 AM ET, Novavax stock rose 11.7% to $49.88 in the pre-market session. The company received $60 million for its coronavirus vaccine candidate.
Novavax Soared 20% on Coronavirus Vaccine Hopes
Today at 4:37 AM ET, Novavax stock rose 20% to $55.40 in the pre-market session. The company started the Phase I study of NVX-CoV2373.
Why Moderna and Novavax Are Smart Long-Term Buys
On Monday, Oppenheimer analyst Hartaj Singh raised its target price on Moderna stock to $108 from $62 with an “outperform” rating.
Coronavirus Vaccine: Novavax and Moderna Lead the Race
Novavax stock rose almost 133% in the week ended May 15 and closed at $43.63. The stock has generated returns of 552% in the last 12 months.